Table 2. Hazard of (a) Infection, (b) Hospitalization, and (c) Delayed Graft Function and Acute Rejection within the First Year Post Kidney Transplant Among HIV Infected Recipients, by Induction Therapy.

(a) Infections*
	No Induction	Any Induction	ATG	Anti-IL2R
UTI	Reference	0.530.881.46	0.601.061.88	0.591.031.79
Sepsis	Reference	0.250.511.04	0.310.721.70	0.290.641.43
Pneumonia	Reference	0.250.611.53	0.100.381.35	0.330.791.91
AIDS-Defining	Reference	0.350.952.61	0.300.932.84	0.641.674.36
Other Intestinal Infections	Reference	0.441.062.58	0.341.153.86	0.681.975.71
CMV	Reference	0.220.782.79	0.100.502.47	0.631.966.06
Oral Candidiasis	Reference	0.883.6815.36	0.482.8016.23	1.616.4425.75
C. Difficile	Reference	0.220.661.98	0.050.383.18	0.521.886.79
Any Infection	Reference	0.550.801.18	0.540.871.39	0.701.081.67
(b) Hospitalization**
LOS for KT	Reference	0.750.901.08	0.740.891.08	0.680.820.98
Days in hospital	Reference	0.520.700.95	0.450.691.07	0.470.691.00
Early Hospital Readmission	Reference	0.630.851.15	0.520.781.16	0.710.981.36
(c) Delayed Graft Function and Acute Rejection***
DGF	Reference	0.510.660.84	0.550.730.97	0.520.700.94
Acute Rejection	Reference	0.600.901.34	0.350.590.99	0.490.771.21
Biopsy-Confirmed	Reference	0.550.861.36	0.310.561.03	0.510.841.40

Subscript indicates upper and lower bounds of a 95% confidence interval

Bold indicates statistical significance at p <0.05 level

^*Weighted hazard ratios derived from Cox proportional hazards models

^**Weighted relative rates derived from negative binomial regression (mean LOS and time hospitalized), and modified Poisson regression (EHR)

^***Weighted relative rates derived from modified Poisson regression models

ATG = anti-thymocyte globulin

CMV = cytomegalovirus

UTI = urinary tract infection

ATG = anti-thymocyte globulin

LOS = length of stay

EHR = early hospital readmissions

DGF = Delayed Graft Function